Ms. Leslie Auld reports

SOLARVEST TRANSITION TO NEX

Solarvest Bioenergy Inc., further to press releases dated May 3, 2023, and July 24, 2023, and to the exchange's notice to transfer to NEX dated Sept. 15, 2023, confirms that the exchange has issued a bulletin to transfer the company's securities to NEX effective at the opening on Tuesday, Jan. 9, 2024. Currently, trading remains suspended.

The company is pursuing the sale of the building currently held by Summerville Holdings Inc. pursuant to an executed agreement between Eversea, the company's 100-per-cent wholly owned subsidiary, and Summerville. Upon completion of the sale, the company intends to repay the principal and all other contractual obligations in full to the shareholders of Summerville. Net proceeds from the sale to be used to restart operations and prioritize other financial obligations.

About Solarvest Bioenergy Inc.

Solarvest is an algae biologics company whose production platform provides it with an extremely flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins.

We seek Safe Harbor.